Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients
- PMID: 21326311
- PMCID: PMC5825003
- DOI: 10.1038/jhg.2011.12
Genome-wide association study identifies genetic variants influencing F-cell levels in sickle-cell patients
Abstract
Fetal hemoglobin (HbF) level has emerged as an important prognostic factor in sickle-cell disease (SCD) and can be measured by the proportion of HbF-containing erythrocytes (F-cells). Recently, BCL11A (zinc-finger protein) was identified as a regulator of HbF, and the strongest association signals were observed either directly for rs766432 or for correlated single-nucleotide polymorphisms (SNPs). To identify additional independently associated genetic variants, we performed a genome-wide association study (GWAS) on the proportion of F-cells in individuals of African ancestry with SCD from the Silent Infarct Transfusion (SIT) Trial cohort. Our study not only confirms the association of rs766432 (P-value <3.32 × 10(-13)), but also identifies an independent novel intronic SNP, rs7606173, associated with F-cells (P-value <1.81 × 10(-15)). The F-cell variances explained independently by these two SNPs are ∼13% (rs7606173) and ∼11% (rs766432), whereas, together they explain ∼16%. Additionally, in men, we identify a novel locus on chromosome 17, glucagon-like peptide-2 receptor (GLP2R), associated with F-cell regulation (rs12103880; P-value <3.41 × 10(-8)). GLP2R encodes a G protein-coupled receptor and involved in proliferative and anti-apoptotic cellular responses. These findings highlight the importance of denser genetic screens and suggest further exploration of the BCL11A and GLP2R loci to gain additional insight into HbF/F-cell regulation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.PLoS One. 2014 Mar 25;9(3):e92506. doi: 10.1371/journal.pone.0092506. eCollection 2014. PLoS One. 2014. PMID: 24667352 Free PMC article.
-
DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11869-74. doi: 10.1073/pnas.0804799105. Epub 2008 Jul 30. Proc Natl Acad Sci U S A. 2008. PMID: 18667698 Free PMC article.
-
BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia.Blood Cells Mol Dis. 2015 Mar;54(3):224-30. doi: 10.1016/j.bcmd.2015.01.001. Epub 2015 Jan 30. Blood Cells Mol Dis. 2015. PMID: 25703683 Free PMC article.
-
Genetic modifiers of HbF and response to hydroxyurea in sickle cell disease.Pediatr Blood Cancer. 2011 Feb;56(2):177-81. doi: 10.1002/pbc.22754. Epub 2010 Sep 9. Pediatr Blood Cancer. 2011. PMID: 20830771 Free PMC article. Review.
-
Transcriptional Repressor BCL11A in Erythroid Cells.Adv Exp Med Biol. 2024;1459:199-215. doi: 10.1007/978-3-031-62731-6_9. Adv Exp Med Biol. 2024. PMID: 39017845 Review.
Cited by
-
Molecular basis of β thalassemia and potential therapeutic targets.Blood Cells Mol Dis. 2018 May;70:54-65. doi: 10.1016/j.bcmd.2017.06.001. Epub 2017 Jun 20. Blood Cells Mol Dis. 2018. PMID: 28651846 Free PMC article. Review.
-
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Cochrane Database Syst Rev. 2020 Apr 6;4(4):CD012389. doi: 10.1002/14651858.CD012389.pub3. Cochrane Database Syst Rev. 2020. PMID: 32250453 Free PMC article.
-
Beta-thalassemia: from genotype to phenotype.Haematologica. 2011 Nov;96(11):1573-5. doi: 10.3324/haematol.2011.055962. Haematologica. 2011. PMID: 22058279 Free PMC article. No abstract available.
-
Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach.BMC Genomics. 2014 Feb 6;15:108. doi: 10.1186/1471-2164-15-108. BMC Genomics. 2014. PMID: 24502199 Free PMC article.
-
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level.Science. 2013 Oct 11;342(6155):253-7. doi: 10.1126/science.1242088. Science. 2013. PMID: 24115442 Free PMC article.
References
-
- Motulsky AG. Frequency of sickling disorders in U.S. blacks. N. Engl. J. Med. 1973;288:31–33. - PubMed
-
- Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 1994;330:1639–1644. - PubMed
-
- Watson J. The significance of the paucity of sickle cells in newborn Negro infants. Am. J. Med. Sci. 1948;215:419–423. - PubMed
-
- Jacob GF, Raper AB. Hereditary persistence of foetal haemoglobin production, and its interaction with the sickle-cell trait. Br. J. Haematol. 1958;4:138–149. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical